Related by context. All words. (Click for frequent words.) 69 mGluR4 mGluR2 mGluR5 66 mGluR2 64 mGluR4 63 #D#C# 63 A3 adenosine receptor 63 selective inhibition 62 Epothilones 62 vanilloid receptor 62 G Protein Coupled 61 PDE4 61 Exelixis compounds 61 #HT#A 61 histone deacetylase HDAC 61 Protein Kinase C 61 partial agonist 61 sodium glucose cotransporter 61 ADP receptor antagonist 61 peripherally acting 61 cyclin dependent kinase inhibitor 61 FLT3 61 RGB # 61 Receptors GPCRs 61 proteasome inhibitors 60 PTP 1B 60 TLR8 60 humanized anti 60 VEGF receptor 60 novel peptide 60 Factor Receptor 60 nicotinic acetylcholine receptor 60 kinase inhibitors 60 small molecule thrombopoietin 60 synthetic siRNA 60 neuronal nicotinic receptors NNRs 60 agonists antagonists 60 5 HT6 59 Preclinical studies suggest 59 TAFA# 59 Fc fusion protein 59 humanized antibodies 59 receptor antagonists 59 metabotropic glutamate receptor 59 CB1 antagonists 59 NS4A 59 opioid receptor antagonist 59 allosteric modulator 59 immune modulatory 59 Elvitegravir 59 selective antagonists 59 TLR9 agonists 59 selective antagonist 59 humanized antibody 59 polymerase inhibitor 59 HSP# inhibitor 59 small molecule inhibitors 59 Delta opioid receptor 59 monoclonal antibodies 59 JAK1 59 PDE7 59 PDGF receptor 59 pan HDAC inhibitor 59 small molecule defensin 59 PDE4 inhibitor 59 rxRNA 59 TLR9 agonist 59 fusion proteins 59 5 HT2A serotonin 59 SARMs 59 PDE# 59 muscarinic 59 antisense drug 58 FGFR 58 MEK inhibitors 58 SIRT1 activators 58 anticancer therapies 58 oral prodrug 58 tubulin inhibitor 58 humanized monoclonal 58 PI3 kinase 58 HDACi 58 mGluR2 NAM 58 Pazopanib 58 diarrhea predominant irritable 58 P#X# 58 effector function 58 proteasome inhibitor 58 humanized monoclonal antibody 58 SGLT2 inhibitors 58 GABAB receptors 58 JAK inhibitor 58 RhuDex ® 58 dependent cellular cytotoxicity 58 orally dosed 58 myelofibrosis polycythemia vera 58 selective inhibitors 58 YONDELIS 58 PI3K inhibitors 58 IAP inhibitor 58 therapeutic monoclonal antibodies 58 AEG# 58 peptidic compound 58 allosteric 58 Monoclonal antibodies 58 5 HT6 receptor 58 Nanobody ® 58 selective modulator 58 somatostatin analogue 58 Notch receptors 58 peroxisome proliferator activated 58 non nucleoside 58 TNFα 58 Anticalins R 58 HuLuc# 58 Factor VEGF 58 protein tyrosine phosphatases 58 HCV protease inhibitors 58 MEK inhibitor 58 Janus kinase 58 agonism 58 Milnacipran 58 Homspera TM 57 NovaBay Aganocide compounds 57 glycosylation profile 57 targeting CD# 57 5 HT2A receptor 57 adenosine receptor 57 CTLA 4 57 pegylated interferons 57 vascular disrupting agents 57 investigational humanized monoclonal antibody 57 Solazed TM 57 huC# DM4 57 ZFP TFs 57 Vaccinex 57 MTP inhibitor 57 5 HT2A inverse 57 CCR3 57 p# inhibitor 57 siRNA therapeutics 57 Aviptadil 57 EGFr 57 Zoraxel 57 5 HT1A receptor 57 CCX# 57 HER3 57 Vidofludimus 57 NKG2D 57 endogenous ligand 57 RNA antagonist 57 VEGF inhibitors 57 highly selective inhibitor 57 Bortezomib 57 Leukine ® 57 CD# monoclonal antibody 57 Vorinostat 57 targeted radiotherapeutic 57 Ocrelizumab 57 agonists 57 Allovectin 7 R 57 5 HT4 receptor 57 monoclonal 57 anti CD3 57 ErbB3 HER3 57 Onalta 57 lysophosphatidic acid LPA 57 CORT # 57 Azixa 57 polymerase inhibitors 57 SERMs 57 Zolinza 57 Adenosine A2A 57 novel anticancer 57 epothilone 57 receptor subtype 57 coronary vasodilation 57 peptidomimetic 57 antisense compounds 57 Romidepsin 57 HER1 57 immunomodulatory effects 57 antibody cytokine 57 calcitonin gene related 57 mu opioid receptor antagonist 56 selectively inhibit 56 pharmacokinetic interactions 56 NTDDS 56 Intravenous Human 56 receptor agonists 56 immunotherapeutics 56 potent antiproliferative 56 antibody therapeutics 56 nucleoside analogues 56 nicotinic alpha 7 56 N methyl 56 Aurora kinase 56 CCR9 antagonist 56 small molecule modulators 56 anticancer therapeutics 56 subtype selective 56 sodium glucose transporter 56 humanized monoclonal antibodies 56 inhibit KSP 56 enzyme inhibitor 56 Factor VIIa 56 synthetic retinoid 56 mGluR5 antagonists 56 immunomodulation 56 p# inhibitors 56 EGFR HER 56 docetaxel Taxotere ® 56 Nanobodies 56 topoisomerase 56 selective kinase inhibitor 56 EGFR inhibitors 56 AMPK activators 56 Anidulafungin 56 mertansine 56 PDE4 inhibitors 56 JAK2 inhibitor 56 FasL 56 delta isoform 56 PI3K/mTOR 56 serine proteases 56 Hsp# inhibitors 56 JAK inhibitors 56 Pimavanserin 56 multitargeted 56 MKC# MT 56 Disease IBD 56 molecularly targeted 56 Gefitinib 56 Factor Xa inhibitor 56 acadesine 56 Maribavir 56 CB2 receptor 56 Anticalin R 56 Luteinizing Hormone Releasing Hormone 56 Nexavar ® 56 selective androgen receptor modulators 56 TLR agonists 56 dopamine D2 56 ENMD # 56 interleukin IL -# 56 HDAC inhibition 56 coupled receptor GPCR 56 Tumor Necrosis Factor 56 secretory phospholipase A2 56 Interferon beta 56 receptor partial agonist 56 isoform selective 56 potent inhibitors 56 Flt3 56 monoclonal antibody mAb 56 5 lipoxygenase 56 GPCR targets 56 hypoxia inducible factor 56 tubulin binding 56 IAP inhibitors 56 adipiplon 56 5 HT1A 56 novel orally administered 56 Panzem R NCD 56 mda 7 56 PPARγ 56 PPARg 56 Aurora kinases 56 immunomodulatory 56 SGLT inhibitors 56 histone deacetylase HDAC inhibitors 56 Debio 56 Immunotherapeutic 56 histone deacetylases 56 EZN 56 monoclonal antibody 56 Th2 cytokines 56 SGLT2 56 Bicifadine 56 mGluR5 antagonist 56 Chemokine Receptor 56 HCV protease 56 anti amnesic 56 anti CD3 antibody 56 RECOTHROM R 56 glucagon receptor 56 BCR ABL inhibitors 56 Xanafide 56 tumor antigen 56 novel immunomodulatory 56 CCR2 56 selective relaxant 56 pathophysiological effects 56 CDKs 55 Dalbavancin 55 Locked Nucleic Acid LNA 55 JAK#/JAK# 55 receptor modulators 55 agonist compounds 55 induce apoptosis 55 OXIGON TM 55 EGF receptor 55 Squalamine 55 microtubule inhibitor 55 2 inhibitor CYT# 55 Onconase 55 Medarex UltiMAb R 55 novel VDA molecule 55 alpha#beta# 55 BAY #-# 55 CRF1 receptor 55 anti infective treatments 55 protein kinase inhibitor 55 targeted antifolate 55 Anticalin ® 55 dacetuzumab 55 chemokine receptors 55 ZFPs 55 histone deacetylase inhibitor 55 receptor tyrosine kinase inhibitor 55 peptide antigens 55 PI3K inhibitor 55 therapeutic antibody 55 NNRs 55 5alpha reductase 55 nicotinic receptor 55 CYT# potent vascular disrupting 55 antisense drugs 55 agonistic human 55 adenosine A2A 55 Tasimelteon 55 oral antiviral 55 c MYC 55 oncoproteins 55 CGRP 55 histone deacetylase HDAC inhibitor 55 SAR# [002] 55 Vidaza azacitidine 55 Ceflatonin 55 metaglidasen 55 Ofatumumab 55 XmAb# 55 mTOR mammalian target 55 preclinically 55 poly ADP ribose polymerase 55 geldanamycin 55 ERK1 2 55 Fibroblast Growth Factor Receptor 55 MAbs 55 RANK Ligand 55 neuroprotective properties 55 soluble tumor necrosis 55 TELINTRA 55 Alfacell proprietary ribonuclease 55 Pathway Inhibitor 55 angioedema indications 55 IFNs 55 glucocorticoid receptor 55 HMG CoA reductase inhibitors 55 Carfilzomib 55 non nucleoside HCV 55 Anticalins ® 55 #HT# 55 pro angiogenic 55 selectively inhibited 55 apoptotic pathway 55 brain penetrant 55 drugable targets 55 V#F mutation 55 MyVax R 55 prophylactic vaccines 55 iobenguane 55 Ustekinumab 55 SIRT2 55 GMX# 55 TNFa 55 selective inverse agonist 55 antitumor 55 immunotherapeutic 55 PRT# 55 cannabinor 55 HIF 1alpha 55 Nedd4 55 Myolimus 55 receptor agonist 55 Tyrima 55 nanocarriers 55 erlotinib Tarceva ® 55 selective adenosine 55 tezampanel 55 cytostatic 55 anticancer compounds 55 casein kinase 55 defensin mimetic antibiotic 55 Hsp# inhibition 55 thymidylate synthase TS 55 Affibody ® molecules 55 mitotic kinesins 55 candidate deforolimus 55 taxol 55 HSP# inhibitors 55 Onalta ™ 55 IgG antibodies 55 HDAC inhibitor 55 BMS # 55 novel orally bioavailable 55 PEGylated Fab fragment 55 XL# XL# 55 myeloproliferative diseases 55 CTLA4 Ig 55 Golimumab 55 NGX# 55 bioactive lipids 55 novel histone deacetylase 55 5 HT2A 55 antiemetic 55 IGF IR 55 receptor subtypes 55 IL #R 55 miR #b [002] 55 glucocorticoid receptors 55 anticancer agents 55 OMP #M# 55 oral JAK1 55 ocular formulation 55 biased ligand 55 CCR9 55 receptor antagonist 55 sPLA2 55 cortisol receptor 55 constitutively active 55 pertuzumab 55 Sphingomab 55 TNFalpha 55 antisense oligonucleotide 55 small molecule activators 55 chimeric monoclonal antibody 54 HuMax CD# 54 cytotoxic 54 resolvins 54 intracellular signaling pathways 54 Valdoxan 54 splice variants 54 serotonin receptor 54 antisense oligonucleotides 54 enhance ApoA 54 dasatinib Sprycel 54 oncolytic 54 PPAR gamma agonists 54 peptide CGRP 54 PDE#A 54 Epidermal Growth Factor Receptor 54 Wnt signaling pathway 54 enkephalin 54 carbohydrate polymer 54 diagnostic molecular imaging 54 antisense inhibitors 54 HDACs 54 antibody MAb 54 calcineurin inhibitors 54 phosphatases 54 Lenalidomide 54 PNP inhibitor 54 Dapagliflozin 54 selective serotonin 2C receptor 54 oral Janus kinase 54 anionic backbone 54 VEGF receptors 54 ligand TRAIL 54 THR beta agonist 54 EP1 receptor 54 androgen receptor AR 54 S#P# 54 CB2 receptor selective 54 EGFR antibodies 54 inhibit EGFR 54 BRAF kinase 54 TRX1 54 synthetic cannabinoid compounds 54 cMET 54 samarium Sm 54 tiapamil 54 sphingosine 1 54 GPR# agonists 54 adenoviral 54 prostaglandin D2 54 phosphate S1P 54 human monoclonal antibody 54 taxane derivative 54 imatinib Gleevec 54 fluoroquinolone antibiotic 54 investigational therapies 54 siRNA therapeutic 54 reslizumab 54 KRN# 54 NF kappaB pathway 54 epothilones 54 IMiDs ® 54 CENP E 54 MAGE A3 ASCI 54 orally administered inhibitor 54 Bioral 54 serine protease 54 immune modulating 54 GSK3B 54 nicotinic 54 Vilazodone 54 methyl D aspartate 54 Ecallantide 54 cyclin dependent kinases 54 histone deacetylase inhibitors 54 TPI ASM8 54 small molecule activator 54 antidiabetic 54 lentiviral vectors 54 TRPV1 agonist 54 AMPAKINE 54 nucleoside analogs 54 oncology indications 54 disease modifying 54 AT1R 54 IGF 1R 54 Ixabepilone 54 Lixivaptan 54 VDAs 54 EP #R 54 Scancell 54 Campath ® 54 vorinostat 54 HepaGam B 54 BiTE antibody 54 Archexin 54 neuropsychiatric diseases 54 NXL# 54 DGAT 54 Talabostat 54 orally bioavailable 54 Pertuzumab 54 AAG geldanamycin analog 54 prodrugs 54 small molecule inhibitor 54 TLR9 54 endogenous ligands 54 c Raf kinase 54 diagnostic biomarkers 54 PDE7 inhibitors 54 Tumor necrosis factor 54 immunoregulatory 54 CEACAM1 54 Interferons 54 nucleotide analogs 54 IgG1 54 Liposomal 54 Spiegelmers ® 54 HER2 receptor 54 HGS ETR2 54 bispecific 54 Daclizumab 54 thrombin receptor 54 selective orally bioavailable 54 T#I [002] 54 monoclonal antibody therapeutics 54 aurora kinase 54 HQK 54 therapeutic monoclonal antibody 54 highly selective endothelin 54 rxRNA ™ compounds 54 short interfering RNA 54 Ganciclovir 54 Symadex 54 anti angiogenic drugs 54 insulin sensitizer 54 nitric oxide donating 54 CD# antibody [001] 54 Monoclonal Antibody 54 novel antibody therapeutics 54 inverse agonist 54 PXD# 54 anti CD3 monoclonal 54 immunotherapies 54 ErbB3 54 Pralatrexate 54 topical formulations 54 dihydrochloride Tablets 54 Metallophile ™ Technology 54 microRNA therapeutics 54 ddRNAi 54 LymphoStat B belimumab 54 Monoclonal antibody 54 anti CD# antibodies 54 azoles 54 enzyme inhibitors 54 D aspartate NMDA receptor 54 renin inhibitor 54 recombinant antibodies 54 chemotherapy induced neutropenia 54 BiTE 54 siRNA mediated 54 cathepsin K 53 CD# CEA 53 peptibody 53 pegylated 53 clinically validated targets 53 Blinatumomab 53 ALN TTR 53 antisense inhibitor 53 Panzem R 53 protein tyrosine phosphatase 1B 53 M2 subunit 53 Interferon alpha 53 Antisense 53 Hsp# chaperone system 53 Virulizin ® 53 Isogenica 53 melanocortin receptors 53 Traficet EN 53 small molecule 53 Hypoxia Inducible Factor 53 Cethrin R 53 prostanoid 53 cyclooxygenase 53 LHRH 53 phage display 53 LPA1 receptor 53 ALN PCS 53 partial agonists 53 mAbs 53 immuno inflammatory diseases 53 trastuzumab Herceptin 53 multi kinase inhibitor 53 potently inhibit 53 acetylcholine receptor 53 factor TNF 53 mediate antibody 53 Anavex #-# 53 FKBP# 53 PEGylated 53 luteinizing hormone releasing 53 Archemix Corp. 53 antitumoral 53 phosphodiesterase inhibitors 53 Clusterin 53 costimulatory 53 immunostimulatory 53 small molecule tyrosine 53 antifibrotic 53 BioVant 53 small molecule glucokinase 53 selective immunoproteasome inhibitor 53 epigenetic therapies 53 Multimeric 53 AEGR 53 monoclonal antibody MAb 53 CB1 receptors 53 deacetylase 53 GW# [003] 53 NF kB pathway 53 inhibit angiogenesis 53 therapeutically relevant 53 IL# PE 53 small molecule agonists 53 fluoropyrimidine 53 prostone 53 CXCR4 receptor 53 biologic therapeutics 53 therapeutic peptide 53 OXi# 53 Pancreate 53 ALTROPANE 53 Cancidas 53 SGLT1 53 FOLOTYN ® 53 VitiGam 53 monoclonal antibodies mAbs 53 Xencor XmAb 53 c MET 53 hormone LHRH antagonist 53 IgG1 monoclonal antibody 53 XmAb ® 53 NuMimetic TM 53 LNP formulations 53 QUADRAMET R 53 Aurora kinase inhibitor 53 HIV integrase inhibitor 53 oxazolidinone 53 mitotic kinesin 53 Aflibercept 53 deacetylase inhibitors 53 GPR# [002] 53 Adenosine 53 Tß4 53 brostallicin 53 LentiVector technology 53 Apo2L 53 anti angiogenic therapies 53 novel peptides 53 polysaccharide polymer 53 Prostacyclin 53 anti EGFR antibody 53 pRb 53 TGF alpha 53 thrombopoietin 53 Genentech Herceptin 53 cleavable linker 53 anticancer drugs 53 C5aR 53 synthetic peptide 53 AZD# 53 cytoprotective 53 A2A adenosine receptor 53 tyrosine kinase inhibitor 53 glycosylated 53 HCV polymerase 53 K ras mutations 53 Oral NKTR 53 stable nucleic acid 53 small molecule therapeutics 53 immunostimulatory effects 53 sd rxRNA 53 pDCs 53 chemokine receptor 53 Zemiva TM 53 therapeutic 53 RECOTHROM ® 53 integrase inhibitor 53 immunomodulating 53 uric acid lowering 53 oral anticancer 53 R#/MEM # 53 CDK inhibitor 53 tyrosine kinase receptor 53 IgG1 antibody 53 Aganocide ® 53 YONDELIS R 53 POTELLIGENT ® 53 mAb 53 reversible inhibitor 53 autoantigen 53 PKC# 53 GM CSF 53 myeloproliferative disorders 53 insulin sensitizers 53 Small Molecule 53 CCR5 antagonist 53 Personalized Immunotherapy 53 factor receptor FGFR 53 receptor inhibitor 53 antiviral compounds 53 stem cell therapeutics 53 hedgehog pathway 53 Orally administered 53 MAGE A3 53 mecamylamine 53 Mipomersen 53 endothelin receptor 53 CCR1 53 XmAb TM 53 Nanobody 53 NY ESO 53 antibody fragment 53 pregabalin Lyrica 53 anti secretory 53 ophthalmic diseases 53 kinase inhibition 53 tricyclic 53 immunomodulators 53 MORAb 53 engineered proteases 53 TTR gene 53 aptamer therapeutics 53 ETBs 53 immunotherapeutic approaches 53 PARP inhibitor 53 cytotoxic agents 53 KLF4 53 2A receptor agonist 53 transient receptor 53 Y2 receptor 53 selective androgen receptor modulator 53 Nanobodies R 53 uricase 53 opioid receptors 53 echinocandins 53 receptor CXCR4 53 MMAE 53 Janus Kinase 53 drug metabolizing enzymes 53 fusion inhibitor 53 Vitaxin 53 Epratuzumab 53 #ME# 53 Cyclooxygenase Inhibiting Nitric Oxide 53 CCR5 inhibitor 53 CRTH2 53 LibiGel ® 53 Cetrorelix 53 Locked Nucleic Acid 53 activin receptor type 53 potent cytotoxic 53 NK1 53 Sym# 53 Amigal 53 insulin sensitizing 53 CEQ# 53 angiogenesis inhibitor 53 TNF á 53 anticancer therapy 53 class mGluR5 inhibitor 53 proteins peptides 53 Hedgehog signaling pathway 53 otelixizumab 53 Pyridorin 53 5 HT2C 53 vidofludimus 53 renin inhibitors 53 Akt inhibitor 53 immunomodulatory properties 53 gamma secretase inhibitors 53 TÎ ² 4 52 Viprovex R 52 LEX System 52 erythropoietic 52 UsiRNAs 52 immunomodulator 52 NEUGENE antisense 52 alpha7 52 monoclonal anti 52 FAAH 52 RAF kinase 52 glutamate receptors 52 sGC 52 cytotoxin 52 immuno modulatory 52 Azedra 52 TREANDA 52 ATL# [001] 52 rxRNA TM compounds 52 antineoplastic 52 pancreatic enzyme replacement 52 antagomirs 52 CompoZr 52 thalidomide Thalomid 52 predictive biomarkers 52 interferon lambda 52 TNF α 52 PORxin TM 52 2 methoxyestradiol 52 GlycoPEG GCSF 52 antimitotic 52 CD# molecule 52 allosteric modulation 52 reuptake inhibitors 52 Tarvacin 52 ganaxolone 52 thyroid hormone receptor 52 DNA plasmids 52 TG# [001] 52 Trastuzumab 52 extracellular signal 52 ACh 52 protein kinases 52 GAP #B# 52 radiotherapeutic 52 HGS ETR1 52 immune modulation 52 incyclinide 52 Micromet BiTE 52 JUVISTA R Human 52 CYC# 52 NPC 1C 52 selective inhibitor 52 chemokine 52 NMDA receptor 52 sodium thiosulfate STS 52 IMC A# 52 pharmacologically 52 Enkephalin 52 HGS# 52 lexidronam injection 52 DOS# 52 direct thrombin inhibitors 52 E#F# 52 Rasagiline 52 kinesin spindle protein KSP 52 molecular biomarkers 52 prostacyclins 52 BAL# [001] 52 cellular immunotherapy 52 mTOR inhibitors 52 multiple sclerosis rheumatoid arthritis 52 nanoviricide 52 OncoVEX GM CSF 52 Vascular Endothelial Growth 52 autoimmune inflammatory 52 chimeric antibody 52 FK# 52 viral vectors 52 oral immunomodulatory 52 neuro inflammatory 52 HuMax CD4 52 vWF 52 TriRima 52 GRN# 52 volociximab 52 catenin 52 Epitomics 52 drug conjugates ADCs 52 micro RNAs 52 siRNAs targeting 52 Omacetaxine 52 PARP inhibitors 52 MET VEGFR2 52 cannabinoid receptor 52 ANG# 52 miR #a [002] 52 maturation inhibitors 52 adrenergic receptors 52 JAK3 52 photosensitizer 52 novel antiviral therapeutics 52 antiangiogenesis therapies 52 shRNA libraries 52 KSP inhibitor 52 kinase inhibitor 52 SIRT1 enzyme 52 Dicer Substrate Technology 52 somatostatin receptors 52 negative allosteric modulator 52 potent anticancer 52 Phenoxodiol 52 Amplimexon 52 immune stimulatory 52 prostaglandin E2 PGE2 52 mitogen activated protein kinase 52 BNC# 52 CD# antibodies 52 selective agonist 52 kidney urologic 52 endothelin receptor antagonists 52 cholesteryl ester transfer 52 adrenergic regulation 52 MAO B 52 Ampakine compounds 52 miRNA therapeutics 52 selective agonists 52 ALB # 52 DNA gyrase 52 E2F 52 antifungal agent 52 retinoic acid receptor 52 #beta HSD1 52 Serdaxin 52 delta opioid receptor 52 Factor VIIa Factor VIII 52 HepDirect 52 GlycoPEGylated hemostasis compounds 52 CB2 selective 52 optical biosensors 52 PPAR gamma 52 nanomolar 52 #beta HSD 1 52 cathepsins 52 systemic RNAi therapeutic 52 survivin 52 CanAg 52 signal transduction inhibitors 52 Amphotericin B 52 cancer immunotherapies 52 non nucleoside inhibitor 52 ERa 52 Gammagard Liquid 52 AtuRNAi 52 depsipeptide 52 Survivin 52 inhibitory effects 52 Rebif ® 52 tumor specific antigen 52 echinocandin 52 telomerase therapeutic 52 Methylnaltrexone 52 vascular disrupting agent 52 radezolid 52 HAAH 52 GSK# [002] 52 beta adrenergic 52 XP #L 52 Enzastaurin 52 adrenoceptor 52 estrogen receptor beta 52 fusion enhancers 52 Smac mimetic 52 5 HT2B receptor 52 protein kinase C 52 VEGF pathway 52 HMG CoA reductase 52 inhibitory receptor 52 PAK1 52 immunotoxins 52 Olaparib 52 selectively inhibits 52 vitro assay